Press release
Increasing Geriatric Population Likely to Fuel the Growth of Kidney Cancer Drugs Market
This is when additional treatment regimens are recommended and immunotherapies and targeted therapies come into play. Kidney cancer drugs are considered to increase the overall lifespan, particularly in patients having an advanced stage of metastatic tumors.
Download PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=537
As mentioned in the report, the increasing occurrence of kidney cancer and the rising aging population globally are amongst the key factors stimulating the growth of the market for kidney cancer drugs. In addition, several novel molecules receiving approval globally is also a prime factor fuelling the market. On the other hand, the soaring prices of branded cancer drugs may restrain the growth of the market. In addition, the rising inclination of the consumers towards generic drug variants may also have a negative impact on the market’s development.
In terms of drug, the market is segmented into Sutent (Sunitinib), Afinitor (Everolimus), Nexavar (Sorafenib), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib), Proleukin (Aldesleukin), and Torisel (Temsirolimus). Amongst these, on the basis of revenue, Sutent led the market in 2013 owing to Sutent being the majorly prescribed drug in the first-line treatment for kidney cancer. In addition, Sutent is also amongst the top studied drugs within its class for multiple indications, as it targets multiple receptor tyrosine kinases (RTKs).
On the other hand, Votrient is predicted to emerge as a market leader by 2017 and is expected to surpass Sutent and all other competitors owing to its unique first-line penetration and low pricing. Votrient exhibited a whopping CAGR of more than 40% between 2012 and 2016.
Geographically, the report segments the market into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, North America leads the kidney cancer drugs market owing to the presence of a huge patient pool having different kinds of cancers of the kidney and the commercial penetration of top branded drugs for the treatment of kidney cancer in this region.
On the other hand, Asia Pacific is also predicted to grow exponentially in the market owing to the increasing aging population and the increasing occurrence of renal cell carcinoma in this region. Furthermore, the economic advancement of nations such as China, India, Malaysia, and Singapore will also stimulate the growth of the market in the region of Asia Pacific.
Browse Report: http://www.transparencymarketresearch.com/kidney-cancer-drugs-market.html
According to the report, the chief players operating in the market for kidney cancer drugs are Novartis AG., F. Hoffman-La Roche., Pfizer, Inc., Bayer Pharma AG., and GlaxoSmithKline, plc., among others.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increasing Geriatric Population Likely to Fuel the Growth of Kidney Cancer Drugs Market here
News-ID: 453531 • Views: …
More Releases from TMR
Emerging Opportunities in Logistics Market with Current Trends Analysis
The global Logistics market is estimated to attain a valuation of US$ 15,273.21 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.5% during the forecast period, 2019-2027.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the…
Energy Measurement IC Market is expected to reach US$ 8.39 Bn by the end of 2031
According to a Transparency Market Research (TMR) research report, the global energy measurement ic market is likely to expand at a CAGR of 7.4% during the forecast period, 2022 to 2031. This suggests that the market is expected to reach US$ 8.39 Bn by the end of 2031.
The study on the energy measurement ic market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The…
STATCOM UPS Market to Register Double Digit Growth Rate of 16% CAGR by 2024
Over the last decade, rising number of industries and utilities are opting for static synchronous compensator or STATCOM UPS instead of static VAR compensator or SVC UPS. Low harmonic emission coupled with high speed of response is accentuating the expansion of India STATCOM UPS market now and in times to come. Playing a crucial role in voltage control and compensation of reactive power, STATCOM UPS is likely to keep its…
Thin Wafer Processing and Dicing Equipment Market US$692.5 mn by 2024 - TMR
Transparency Market Research (TMR) estimates that the global thin wafer processing and dicing equipment market has a highly consolidative landscape. Disco Corp. accounted for largest share of 56.4% in 2015 and likely to be dominant in the coming years. This is creating monopoly in the thin wafer processing and dicing equipment market in terms of competitive presence. The other key players such as EV Group, Plasma-Therm LLC, Lam Research Corp,…
More Releases for Sutent
Sunitinib Malate (CAS 341031-54-7) Market to Witness Huge Growth by Key Players: …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Sunitinib Malate (CAS 341031-54-7) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Sunitinib Malate (CAS 341031-54-7) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Sunitinib Malate (CAS 341031-54-7)…
Global Sunitinib Malate (CAS 341031-54-7) Market 2021 to 2026 - Growth, Opportun …
Global Sunitinib Malate (CAS 341031-54-7) Market Growth 2021-2026 analysis with precise estimates and predictions by MarketsandResearch.biz gives you complete research solutions for strategic decision-making targeted at giving maximum industry clarity. This study provides ideas for rational decisions to deliver optimum market insight, including Sunitinib Malate (CAS 341031-54-7) market analysis with precise estimates and forecasts. Along with these, the changing industry trends and other key market factors have been thoroughly explored.…
Global Sunitinib Malate (CAS: 341031-54-7) Market Report Overview 2019-2025 | Ma …
A newly compiled business intelligent report, titled “Global Sunitinib Malate (CAS: 341031-54-7) Market Size, Status and Forecast 2019-2025” has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study revolves around the analysis of (Sunitinib Malate) market, covering key industry developments and market opportunity map during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned market, providing a 360…
Kidney Cancer Drugs Market: In terms of revenue, Sutent was the largest-selling …
The global kidney cancer drugs market is dominated by a few global giants, namely F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, GlaxoSmithKline plc, and Pfizer, Inc. This makes the competitive landscape highly consolidated in nature. Competition among the players is stiff too.
Biopharmaceutical behemoth Pfizer, Inc., among them, led the global market for kidney cancer drugs with maximum share in 2013 on the back of Sunitinib and Axitinib,…
Kidney Cancer Drugs Market to expand at a 6.6% CAGR with growing geriatric popul …
The global kidney cancer drugs market is dominated by a few global giants, namely F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, GlaxoSmithKline plc, and Pfizer, Inc. This makes the competitive landscape highly consolidated in nature. Competition among the players is stiff too.
Biopharmaceutical behemoth Pfizer, Inc., among them, led the global market for kidney cancer drugs with maximum share in 2013 on the back of Sunitinib and Axitinib,…
Global Sunitinib Malate (CAS：341031-54-7) Market 2017 - Pfizer Sutent, Topcare …
To begin with, the report defines the Sunitinib Malate (CAS:341031-54-7) market and segments it based on the most important dynamics, such as applications, geographical/regional markets, and competitive scenario. Macroeconomic and microeconomic factors environments that currently prevail and also those that are projected to emerge are covered in this report.
Download Free Sample Report @ https://www.fiormarkets.com/report-detail/62131/request-sample
The report’s analysis is based on technical data and industry figures sourced from the most reputable databases.…
